Abstract：【Objective】To investigate the relationship of proliferative diabetic retinopathy (PDR) with serum magnesium and glycosylated albumin in patients with type 2 diabetes mellitus (T2DM). 【Methods】A total of 90 patients with T2DM in our hospital from October 2017 to December 2018 were selected and divided into the proliferative diabetic retinopathy (PDR) group (n=42 cases) and non-proliferative diabetic retinopathy (NPDR) group (n=48 cases) according to the occurrence of PDR or not. The level of serum glycosylated albumin was detected by immunoturbidimetry and the level of serum magnesium was measured by enzyme-linked immunosorbent assay. The ROC curve was used to analyze the diagnostic efficacy of serum magnesium and glycosylated albumin in patients with T2DM complicated with PDR. In addition, logistic regression analysis was used to analyze the risk factors of PDR in patients with T2DM. 【Results】Compared with the NPDR group, the serum magnesium level in the group with PDR was lower (P<0.05), and the glycosylated albumin level was higher (P<0.05). The ROC curve showed that the area under curve (AUC) of serum magnesium and glycosylated albumin in the diagnosis of PDR in patients with T2DM were 0.699 and 0.768, their cut-off values were 0.79 mmol/L and 16.35%, respectively. The AUC of combined diagnosis of magnesium and glycosylated albumin was 0.857, which was significantly higher than that of serum magnesium and glycosylated albumin alone (P<0.05), the sensitivity and specificity were 71.4% and 87.5%, respectively. Serum magnesium, glycosylated albumin, triglyceride (TG), course of disease were the risk factors of PDR in patients with diabetes mellitus (P<0.05). 【Conclusion】The serum magnesium of patients with T2DM with PDR is significantly reduced, while glycosylated albumin is abnormally elevated, and both are risk factors for T2DM with PDR, which can be used as potential indicators for later disease diagnosis.
赵辉, 邵晓涵. 2型糖尿病患者血清镁、糖化白蛋白与增殖性糖尿病性视网膜病变发生的相关性分析[J]. 医学临床研究, 2022, 39(2): 198-200.
ZHAO Hui, SHAO Xiao-han. Relationship of Proliferative Diabetic Retinopathy with Serum Magnesium and Glycosylated Albumin in Patients with Type 2 Diabetes Mellitus. JOURNAL OF CLINICAL RESEARCH, 2022, 39(2): 198-200.
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[2] CHAWLA A.Microvasular and macrovascular complications in diabetes mellitus:Distinct or continuum[J].Indian J Endocrinol Metab,2016,20(4):546-551.
[3] 桑艳红,甄月巧,王楚楚.血清ANGPTL3水平与2型糖尿病视网膜病变的相关性分析[J].医学临床研究,2021,38(1):156-158.
[4] 李磊,孔倩倩,王丽,等.2型糖尿病患者视网膜病变的危险因素分析[J].检验医学与临床,2019,16(11):1503-1505.
[5] 刘贞.糖化白蛋白、糖化血红蛋白在2型糖尿病及并发症中的诊断价值研究[J].系统医学,2018,3(10):24-26.
[6] 王珊珊,陈莉明,常宝成,等.2型糖尿病患者血清钙与糖代谢的相关关系[J].中华内分泌代谢杂志,2014,30(1):26-30.
[7] 商书霞,刘晓耕,吕飞,等.2型糖尿病增殖期视网膜病变患者血清胆红素、镁离子水平变化及意义[J].山东医药,2016,56(46):24-26.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志, 2014,30(10):26-89.
[9] 雷颖庆.糖尿病性视网膜病变患者视网膜病变程度与糖化血红蛋白水平及视网膜血管血氧饱和度的相关性研究[J].医学临床研究,2020,37(6):933-935.
[10] 卢亚男,孙志新,刘丽俊,等.2型糖尿病视网膜病变患者糖化白蛋白和糖化白蛋白/糖化血红蛋白水平的改变及其临床意义研究[J].中国糖尿病杂志,2019,27(4):268-272.
[11] 王艳华,李成,鄢碧珠.GA/HbA1c比值与2型糖尿病周围神经病变相关性研究[J].中国实用神经疾病杂志,2020,23(10):829-832.
[12] JEON W S,PARK S E,RHEE E J,et al.The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2016,116(4):46-53.
[13] 杨舒羽,王明娇,曾素根.血清镁水平与糖尿病前期及糖尿病发生风险的相关性研究[J].川北医学院学报,2018,33(3):395-397.
2022, Vol. 39 
